Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Clinical research

Caplacizumab speeds up resolution of rare thrombotic disorder

Study suggests novel therapy could prevent short and long-term organ damage associated with aTTP.

Scanning electron micrograph (SEM) of a blood clot

Source: Steve Gschmeissner / Science Photo Library

An accumulation of von Willebrand factor causes a condition called acquired thrombotic thrombocytopenic purpura, which can lead to potentially fatal blood clots (pictured)

Acquired thrombotic thrombocytopenic purpura (aTTP) is caused by an accumulation of von Willebrand factor — leading to clots in small blood vessels that can be fatal. 

The rare blood disorder can be treated by plasma exchange and immunosuppressive therapy, but acute episodes are still associated with significant mortality (10–20%) and relapses are common.  

Caplacizumab is an anti-von Willebrand factor humanised single-variable-domain immunoglobulin. Results from a phase II study show that this novel therapy leads to significantly faster resolution of aTTP than placebo in patients also receiving standard-of-care treatment, as shown by a 39% reduction in the median time to platelet normalisation. 

The researchers, who report their findings in The New England Journal of Medicine (online, 11 February 2016)[1], say the results suggest that caplacizumab could potentially prevent short and long-term organ damage associated with aTTP.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20200731

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now
  • Basic Pharmacokinetics

    Basic Pharmacokinetics

    A clear and concise basic pharmacokinetics textbook. Shows how to apply the principles to achieve successful drug therapy.

    £54.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Scanning electron micrograph (SEM) of a blood clot
  • Blood clot micrograph

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.